FGF-12 Protein 2246-FG-025 from R&D Systems, a Bio-Techne Brand | Biocompare.com

Supplier Images
Published Figures

Recombinant Human FGF-12 Protein

Recombinant Human FGF-12 Protein Binding Activity
FGF-12 Protein

FGF-12 Protein
FGF-12 Protein

Recombinant Human FGF-12 Protein Binding Activity

Be the first to write a review!

Citations:

Figures:

Supplier Page from
R&D Systems, a Bio-Techne Brand for
FGF-12 Protein

Product Specs
ItemFGF-12 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $362.00Supplier Page View Company Product Page
Catalog Number2246-FG-025
SpeciesHuman
Size25 ug
Molecule NameFGF-12
NCBI Full Gene Namefibroblast growth factor 12
NCBI Gene AliasesDEE47, FGF12B, EIEE47, FHF1
FormatLyophilized from a 0.2 µm filtered solution in MOPS, Na2SO4 and EDTA with BSA as a carrier protein
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
ApplicationsBinding Activity
Conjugate/TagUnconjugated
Source/Expression SystemE. coli-derived Recombinant Human FGF-12 Protein
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Sizes Available: 25 ug

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditionsJournal of neuroinflammationJanuary 17, 2023Parthasarathy G, Pattison MB, Midkiff CC.(0.1%) was used as a solvent control. Recombinant human FGFs (FGF6 #238F6-025; FGF10-#345-FG-025; FGF12-2246-FG-025) were purchased from R&D systems (Minneapolis, MN). Immunofluorescence (IF) IF was carried out as

(2) Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNatureJuly 26, 2012Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, et al.

(3) Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancerThe American journal of pathologyNovember 1, 2010Tomlinson DC, Knowles MA.

Be the First to Write a Review!